Sigma Planning’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,500
Closed -$214K – 1315
2022
Q2
$214K Hold
1,500
– – 0.01% 1135
2022
Q1
$258K Buy
+1,500
New +$253K 0.01% 1136
2021
Q4
– Sell
-600
Closed -$231K – 1436
2021
Q3
$231K Buy
+600
New +$221K 0.01% 1188

Other funds holding MRNA

Sigma Planning's MRNA Position: Q3 2026 in Review

Sigma Planning opened a new position in Moderna (MRNA) in Q3 2026: 1,492 shares worth $287K. The stake represents 0.01% of the portfolio and ranks #1083 among its holdings. This is a return to the name: Sigma Planning previously reported a position in MRNA as recently as Q1 2026.

Sigma Planning first reported a position in MRNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $10.5M in Q3 2021. 1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Sigma Planning held 1,492 shares of Moderna worth $287K as of Q3 2026.
  • Moderna was a new Sigma Planning position in Q3 2026.
  • Moderna made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #1083 holding.
  • Sigma Planning first reported a position in Moderna in Q1 2020 and has held it in 21 quarters since.
  • Sigma Planning's Moderna position peaked at $10.5M in Q3 2021.
  • 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.